<div><a href="https://www.youtube.com/shorts/Um2nOe5-UwM" target="_blank" rel="noreferrer noopener">Access to Cancer Medicines for all</a>
</div>
<div>What if your survival depended on a medicine you couldn’t afford or even access?
</div>
<div><br />
</div>
<div>This is the devastating reality for millions of people with cancer in low- and middle-income countries (LMICs), where essential cancer drugs remain <strong>out of reach</strong>. Diagnoses often come too late. Pain relief is scarce. And treatment? Sometimes nonexistent.
</div>
<div><br />
</div>
<div>At <a href="https://inspire2live.org" target="_blank" rel="noreferrer noopener">Inspire2Live</a> , we believe that <em>where you live should not determine whether you live</em>. That’s why we’ve launched a global initiative to make lifesaving cancer medicines accessible, <strong>regardless of income, status, or geography.</strong>
</div>
<div>Barbara Moss, a Stage IV colon cancer survivor and Inspire2Live advocate from the UK, remembers what it was like to be denied access to life-saving treatment simply because it was “too expensive”:
</div>
<div><br />
</div>
<div>“If my family hadn’t paid for the biological drug, I would not be alive today. The drug shrank my tumours and gave me the chance to have surgery. Eighteen years later, I’m still here.”
</div>
<div><br />
</div>
<div>And now, she’s fighting for others to have that same chance:
</div>
<div><br />
</div>
<div><strong>“We believe that it is inhumane to allow people to suffer and die when there is a known way of preventing this.”</strong>
</div>
<div><br />
</div>
<div><strong> The Crisis</strong>
</div>
<div><br />
</div>
<div>•	Only <strong>20% of the world’s medicine</strong> reaches <strong>80% of its population.</strong>
</div>
<div><br />
</div>
<div>•	Of the 83 essential cancer drugs listed by WHO, many are simply <strong>unavailable</strong> in LMICs.
</div>
<div><br />
</div>
<div>•	These are not rare, experimental drugs. They’re proven treatments that <strong>could be saving lives today.</strong>
</div>
<div><br />
</div>
<div>This isn’t just a global health issue. It’s a matter of <strong>justice</strong>.
</div>
<div><br />
</div>
<div><strong>The Solution</strong>
</div>
<div><br />
</div>
<div>Just like the successful model for HIV treatment, we can:
</div>
<div><br />
</div>
<div>•	Make medicines under <strong>patent</strong> available as <strong>generics</strong> in LMICs
</div>
<div><br />
</div>
<div>•	<strong>Lower production costs</strong> by up to 90% after use in high-income countries.
</div>
<div><br />
</div>
<div>•	Enable <strong>local manufacturing and registration</strong> <strong>without harming pharma profits.</strong>
</div>
<div><br />
</div>
<div>The science exists. The system works. We just need the will and the funding to make it happen.
</div>
<div><br />
</div>
<div><strong>What Your Donation Will Do</strong>
</div>
<div><br />
</div>
<div>Your support will help us:
</div>
<div><br />
</div>
<div>•	Register essential cancer drugs in LMICs.
</div>
<div><br />
</div>
<div>•	Support local, safe production of generic medicines.
</div>
<div><br />
</div>
<div>•	Launch on-the-ground advocacy and partnerships.
</div>
<div><br />
</div>
<div>•	Ensure <strong>equity in cancer care</strong>, globally.
</div>
<div><br />
</div>
<div>We are backed by <strong>leading scientists, global health leaders, and patient advocates</strong> around the world. But we need <strong>you</strong> to take this movement forward.
</div>
<div><br />
</div>
<div>Please donate today.
</div>
<div>Help us bring cancer care where it’s needed most.
</div>
<div>Because <strong>medicine should heal everyone. Not just the lucky few</strong>.
</div>

Anonymous

Célimène Galiger

Nicole Stolk

Dini Hilbron

Bas Westerweel

Erik Roos

Peter Hoogweg

Annette Cornelisse

Guido Schouw

Jean-Philippe de Lannoy

Toine Pieters

Parag Mankeekar

Access to Cancer Treatment for all

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Access to Cancer Treatment for all

Still €21,891 to go. Help us build momentum.